Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2005Journal of Dermatological Treatment

A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis

View Full Paper
Ask AI
Bookmark
Share

Authors

MLMark LingMount Sinai Hospital
Alice B. Gottlieb
Alice B. GottliebRutgers, The State University of New JerseyDPDavid M. PariserEastern Virginia Medical School

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ling et al. (2005) studied this question.

synapsesocial.com/papers/6a7f20fb64b9ef61cb69476dhttps://doi.org/10.1080/09546630510033159
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pimecrolimus Cream in the Long-Term Management of Atopic Dermatitis in Adults: A Six-Month Study2002 · 220 citations
  2. 2A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology1999 · 268 citations
  3. 3Pimecrolimus (Elidel, SDZ ASM 981)—Preclinical pharmacologic profile and skin selectivity2001 · 127 citations
  4. 4Efficacy and Safety of Pimecrolimus Cream in the Long-Term Management of Atopic Dermatitis in Children2002 · 404 citations
  5. 5Compliance problems in paediatric atopic eczema1996 · 87 citations